Skip to main content
Co-Diagnostics, Inc. (CODX)
NASDAQ: CODX · Real-Time Price · USD
1.180
-0.030 (-2.48%)
At close: Nov 7, 2024, 4:00 PM
1.190
+0.010 (0.85%)
After-hours: Nov 7, 2024, 5:19 PM EST

Co-Diagnostics Revenue

Co-Diagnostics had revenue of $2.66M in the quarter ending June 30, 2024, with 1,243.15% growth. This brings the company's revenue in the last twelve months to $9.14M, up 25.24% year-over-year. In the year 2023, Co-Diagnostics had annual revenue of $6.81M, down -80.09%.

Revenue (ttm)
$9.14M
Revenue Growth
+25.24%
P/S Ratio
3.93
Revenue / Employee
$58,948
Employees
155
Market Cap
37.65M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20236.81M-27.41M-80.09%
Dec 31, 202234.22M-63.67M-65.04%
Dec 31, 202197.89M23.33M31.30%
Dec 31, 202074.55M74.34M34,579.90%
Dec 31, 2019214.97K175.06K438.63%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
NeueHealth 1.03B
CareCloud 111.75M
Apyx Medical 49.03M
ProPhase Labs 17.97M
BioLineRx 17.05M
SAB Biotherapeutics 2.78M
Lexaria Bioscience 411.02K
Revenue Rankings

CODX News

More News